A practicing nephrologist who runs the medical side of a $1.9 billion device business, and still keeps a standing clinic day.
Most people who reach a job title with "Chief" in it quietly retire from the actual work. The surgeon stops operating. The engineer stops shipping code. The doctor hangs up the white coat and moves into a calendar full of meetings about the work rather than the work itself. Gerald Denny went the other way. He took the corner office and kept the clinic day.
In December 2025, Medtronic named him Vice President and Chief Medical Officer of its Acute Care & Monitoring business. That unit is not small. It runs to roughly $1.9 billion in annual sales and makes the equipment that hums quietly over hospital beds: pulse oximeters, patient monitors, airway management tools. If you have ever watched a green line trace across a screen while a nurse checks a number, you have met the output of the business Denny now guides on the medical side.
And still, part of his week belongs to a small clinic in Decatur, Georgia, where he sees patients the way he did before any of the titles arrived.
Denny - who goes by "Jeb" - is Gerald B. Denny II, MD, MSCI. The credentials read like a map of restlessness. He earned his medical degree at Wake Forest University School of Medicine, then added a Master of Science in Clinical Investigation at Vanderbilt, the kind of degree you get when you want to understand not just how to treat a patient but how to prove what works. He is board certified twice over, in nephrology and internal medicine, and he came up practicing as both a nephrologist and a hospitalist.
Nephrology is a useful place to start a story like this. Kidney medicine is systems thinking made physical. Nothing in the body stays local; a change in one number ripples into six others. The nephrologist learns to hold the whole picture and to distrust the tidy single explanation. It is not a bad training ground for someone who will one day sit between engineers and clinicians and try to keep both honest.
From clinical medicine, Denny moved into the parts of healthcare most patients never see. He became Chief Medical Officer of the Medical Review Institute of America, a utilization-management company. In plain terms, that is the world of deciding whether care gets approved - reading the appeal, weighing the evidence, saying yes or no. It is unglamorous and easy to caricature, but it is also where you learn, in unforgiving detail, how the system actually spends its money and where the gaps between "recommended" and "reimbursed" hide.
Then came BD, the medical technology giant, where he led medical affairs across a sprawl of businesses: urology and critical care, smart connected care, vascular access devices. Medical affairs is the function that translates. Engineers speak in specifications and clinicians speak in outcomes, and someone has to stand in the middle with a foot in each language. Denny spent years being that someone.
There is a temptation to read the retained clinic day as sentiment - a nice touch, a doctor who loves medicine too much to fully leave. That undersells it. Keeping an active practice while running the medical strategy of a billion-dollar business is a real cost. It bends the calendar. It complicates travel. It is the kind of thing most executives shed on the first day precisely because it is inconvenient.
The inconvenience is the point. A Chief Medical Officer's job, stripped down, is to be the person in the building who cannot be fooled about what care actually feels like. That authority has a short shelf life. It erodes the moment you stop doing the thing. Denny keeps the clinic day the way a chef keeps working the line: not for nostalgia, but to protect the one asset that makes the rest of the role credible.
Consider what that does to a meeting. A product team proposes a change to an alarm threshold, a new default on a monitor, a workflow for an airway tool. Around the table sit people who are brilliant at what they do and who have, in most cases, never been the exhausted clinician at 3 a.m. reading that screen. Then there is Denny, who was recently exactly that person. The conversation gets more honest fast.
The unit Denny now leads medically did not always exist in its current shape. Medtronic exited the ventilator market and consolidated its patient monitoring and respiratory operations into a single Acute Care & Monitoring business. That kind of restructuring leaves a company with a coherent product line but also with the harder work of deciding what it stands for next. A newly consolidated business needs a medical point of view, someone to say what "good" looks like across the whole portfolio rather than one product at a time.
Pulse oximeters, patient monitors, and airway management tools - the quiet infrastructure of a hospital's most-watched screens. It runs to roughly $1.9 billion in annual sales.
On his arrival, the president of the business, Kate Benedict, pointed to his "relentless dedication to putting patient needs first" and framed his expertise as a driver of innovation and growth. It is the kind of thing leaders say about new hires, but the phrase happens to line up with the shape of Denny's whole résumé. He has spent time on nearly every side of the healthcare table - treating patients, deciding what care gets approved, and building the technology that care depends on.
Denny's own framing of the role is modest and specific. He said he was "incredibly excited to join Medtronic and the ACM business at a time when personalized patient care is at the forefront of healthcare." Read past the corporate warmth and there is a thesis in there. Personalized care and monitoring technology are converging. The screen above the bed is becoming less a passive readout and more a system that adapts to the individual patient. Someone has to make sure that shift stays anchored to real clinical need rather than novelty, and that is the job he signed up for.
It helps that he is based in Georgia while the business he serves is run out of Minnesota. Distance is not usually an asset for an executive, but in his case it keeps him near the clinic, near the patients, near the reason the products exist. He leads the medical strategy of a Minnesota device giant from a Georgia clinic waiting room, and the arrangement is not a compromise. It is the design.
What makes the story worth telling is not the size of the number he now oversees. It is the refusal to let the number replace the work. Careers in medicine almost always drift away from the patient - toward administration, toward strategy, toward the abstractions that pay better and demand less at 3 a.m. Denny keeps circling back. The clinic day is the tell. It says he still believes the most important information in his job does not live in a slide deck. It lives in a chart, in a room, with a person whose numbers are moving in the wrong direction and who needs someone paying attention.
That is a rare kind of stubbornness in a person with his title, and it is probably why the title suits him.
Gerald "Jeb" Denny II, MD, MSCI, is the Vice President and Chief Medical Officer of Medtronic's Acute Care & Monitoring business, a physician executive board certified in nephrology and internal medicine.
He leads the medical strategy for the Acute Care & Monitoring business, a roughly $1.9 billion unit that makes pulse oximeters, patient monitors and airway management tools. He took the role in December 2025.
Yes. He continues to spend part of his time practicing at the Physicians' Care Clinic in Decatur, Georgia.
He led medical affairs for urology, critical care, smart connected care and vascular access at BD, and earlier served as Chief Medical Officer of the Medical Review Institute of America.
He earned his MD at Wake Forest University School of Medicine and a Master of Science in Clinical Investigation at Vanderbilt University.